Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent
This study has been withdrawn prior to recruitment.
( Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the medication for the study. )
Study NCT00329316   Information provided by The Baruch Padeh Medical Center, Poriya
First Received: May 23, 2006   Last Updated: June 26, 2008   History of Changes

May 23, 2006
June 26, 2008
 
 
 
 
Complete list of historical versions of study NCT00329316 on ClinicalTrials.gov Archive Site
 
 
 
Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent
 

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

 
 
Interventional
Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
  • Pregnancy
  • Premature Birth
Drug: Crinone Gel 8%
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Withdrawn
 
 
 

Inclusion Criteria:

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies

-

Exclusion Criteria:

  • No medications for PTL or any kind of progesterone.
  • Cervical suture
  • Multiple pregnancy
Female
 
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00329316
 
PTL Progesterone Perlitz.CTIL
The Baruch Padeh Medical Center, Poriya
 
Study Chair: Yuri Perlitz, MD The Baruch Padeh Medical Center, Poriya
Principal Investigator: Mosheh Ben Ami, Prof. Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya
The Baruch Padeh Medical Center, Poriya
June 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP